Yale School of Medicine
Yale School of Medicine
New Haven, Connecticut, United States17 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07176351 | |
| DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes | Female Urogenital Diseases and Pregnancy Complications, Insulin Resistance, Nutritional and Metabolic Diseases, Urogenital Diseases, diabetes mellitus, endocrine system disorder, gestational diabetes, glucose metabolism disease, hyperinsulinism, metabolic disease, pregnancy disorder | Recruiting | Phase 4 | 2026-10-07 | NCT06445946 | |
| Language Network Prehab Via fMRI Neurofeedback | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not applicable | 2026-09-29 | NCT07488780 | |
| Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 3 | 2026-09-17 | NCT06858839 | |
| Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) | Alcohol Use Disorder, Body Weight, Body Weight Changes, Chemically-Induced Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, alcohol-related disorders, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 1 | 2026-09-10 | NCT07223983 | |
| A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-09 | NCT06966453 | |
| Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma | Clear-cell metastatic renal cell carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 1 | 2026-08-27 | NCT04696731 | |
| Mechanisms of Ultrasound Neuromodulation Effects in Diabetes | Insulin Resistance, Insulin Sensitivity, Nutritional and Metabolic Diseases, glucose metabolism disease, hyperinsulinism, metabolic disease | Recruiting | Not applicable | 2026-08-24 | NCT06042517 | |
| Subcortical Arousal in Perceptual Awareness | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Not applicable | 2026-08-10 | NCT06934356 | |
| A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Phase 3 | 2026-07-02 | NCT04849728 | |
| Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, neoplasm, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-06-22 | NCT05573126 | |
| LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions | Angina Pectoris, Chest Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Phase 4 | 2026-04-07 | NCT05786417 | |
| Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Nutritional and Metabolic Diseases, Wilson disease, basal ganglia disorder, brain disorder, central nervous system disorder, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, inherited neurodegenerative disorder, liver disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease | Recruiting | Not stated | 2026-03-05 | NCT07301216 | |
| MyChart Proxy Outreach to Parents (MyPOP) | Health Technology | Recruiting | Not applicable | 2026-02-13 | NCT05989308 | |
| Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection | Aortic Dissection Type B | Active, not recruiting | Not applicable | 2025-11-06 | NCT03033043 | |
| The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP) | Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, recurrent respiratory papillomatosis, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2025-08-12 | NCT06412172 | |
| Systems Investigation of Vaccine Responses in Aging and Frailty | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 2 | 2025-06-12 | NCT05291676 |